,title,publish_time,journal,url,abstract,doi,cord_uid,words
143444,More targeted use of oseltamivir and in-hospital isolation facilities after implementation of a multifaceted strategy including a rapid molecular diagnostic panel for respiratory viruses in immunocompromised adult patients,2019-07-31,Journal of Clinical Virology,https://api.elsevier.com/content/article/pii/S1386653219300770; https://www.ncbi.nlm.nih.gov/pubmed/30999234/; https://doi.org/10.1016/j.jcv.2019.04.003; https://www.sciencedirect.com/science/article/pii/S1386653219300770,"Abstract Background Immunocompromised adults are more vulnerable to a complicated course of viral respiratory tract infections (RTI). Objectives Provide evidence on the effect of implementation of rapid molecular diagnostics for viruses on use of in-hospital isolation facilities, oseltamivir and antibiotic usage, and other clinical outcomes in immunocompromised patients. Study design A before-after study during two consecutive respiratory viral seasons, including immunocompromised adult patients presenting at a tertiary care emergency department with clinical suspicion of RTI. During the first season (2016/2017), respiratory viruses were detected using inhouse real-time PCR. The second season (2017/2018), we implemented a diagnostic flowchart including a rapid molecular test for 15 respiratory viruses (FilmArray®). We assessed the effect of this implementation on need for isolation, antivirals and empirical antibiotics. Results We included 192 immunocompromised adult patients during the first and 378 during the second season. Respiratory viral testing was performed in 135 patients (70%) during the first and 284 (75%) during the second season (p = 0.218) of which 213 (75%) using the rapid test. After implementation, use of in-hospital isolation facilities was reduced (adjusted odds ratio 0.35, 95%CI 0.19-0.64). Furthermore, adequate use of oseltamivir improved, with fewer prescriptions in influenza negative patients (0.15, 95%CI 0.08-0.28) and more in influenza positive patients (11.13, 95%CI 1.75–70.86). No effect was observed on empirical antibiotic use, hospital admissions, length of hospital stay or safety outcomes. Conclusions Implementation of rapid molecular testing for respiratory viruses in adult immunocompromised patients results in more adequate use of oseltamivir and in-hospital isolation facilities without compromising safety.",10.1016/j.jcv.2019.04.003,3cwh5yh7,"['Abstract', 'Background', 'Immunocompromised', 'adults', 'are', 'more', 'vulnerable', 'to', 'a', 'complicated', 'course', 'of', 'viral', 'respiratory', 'tract', 'infections', 'RTI', 'Objectives', 'Provide', 'evidence', 'on', 'the', 'effect', 'of', 'implementation', 'of', 'rapid', 'molecular', 'diagnostics', 'for', 'viruses', 'on', 'use', 'of', 'in', 'hospital', 'isolation', 'facilities', 'oseltamivir', 'and', 'antibiotic', 'usage', 'and', 'other', 'clinical', 'outcomes', 'in', 'immunocompromised', 'patients', 'Study', 'design', 'A', 'before', 'after', 'study', 'during', 'two', 'consecutive', 'respiratory', 'viral', 'seasons', 'including', 'immunocompromised', 'adult', 'patients', 'presenting', 'at', 'a', 'tertiary', 'care', 'emergency', 'department', 'with', 'clinical', 'suspicion', 'of', 'RTI', 'During', 'the', 'first', 'season', '2016', '2017', 'respiratory', 'viruses', 'were', 'detected', 'using', 'inhouse', 'real', 'time', 'PCR', 'The', 'second', 'season', '2017', '2018', 'we', 'implemented', 'a', 'diagnostic', 'flowchart', 'including', 'a', 'rapid', 'molecular', 'test', 'for', '15', 'respiratory', 'viruses', 'FilmArray', 'We', 'assessed', 'the', 'effect', 'of', 'this', 'implementation', 'on', 'need', 'for', 'isolation', 'antivirals', 'and', 'empirical', 'antibiotics', 'Results', 'We', 'included', '192', 'immunocompromised', 'adult', 'patients', 'during', 'the', 'first', 'and', '378', 'during', 'the', 'second', 'season', 'Respiratory', 'viral', 'testing', 'was', 'performed', 'in', '135', 'patients', '70', 'during', 'the', 'first', 'and', '284', '75', 'during', 'the', 'second', 'season', 'p', '0', '218', 'of', 'which', '213', '75', 'using', 'the', 'rapid', 'test', 'After', 'implementation', 'use', 'of', 'in', 'hospital', 'isolation', 'facilities', 'was', 'reduced', 'adjusted', 'odds', 'ratio', '0', '35', '95', 'CI', '0', '19', '0', '64', 'Furthermore', 'adequate', 'use', 'of', 'oseltamivir', 'improved', 'with', 'fewer', 'prescriptions', 'in', 'influenza', 'negative', 'patients', '0', '15', '95', 'CI', '0', '08', '0', '28', 'and', 'more', 'in', 'influenza', 'positive', 'patients', '11', '13', '95', 'CI', '1', '75', '70', '86', 'No', 'effect', 'was', 'observed', 'on', 'empirical', 'antibiotic', 'use', 'hospital', 'admissions', 'length', 'of', 'hospital', 'stay', 'or', 'safety', 'outcomes', 'Conclusions', 'Implementation', 'of', 'rapid', 'molecular', 'testing', 'for', 'respiratory', 'viruses', 'in', 'adult', 'immunocompromised', 'patients', 'results', 'in', 'more', 'adequate', 'use', 'of', 'oseltamivir', 'and', 'in', 'hospital', 'isolation', 'facilities', 'without', 'compromising', 'safety', '']"
151789,Improving Evidence Based Bronchiolitis Care,2018-03-31,Clinical Pediatric Emergency Medicine,https://api.elsevier.com/content/article/pii/S152284011830003X; https://www.sciencedirect.com/science/article/pii/S152284011830003X; https://doi.org/10.1016/j.cpem.2018.02.003; https://www.ncbi.nlm.nih.gov/pubmed/32288646/,"Abstract Bronchiolitis is the number one cause of hospitalization in infants during the first year of life. Clinical guidelines recommend primarily supportive care and discourage use of pharmacotherapies and diagnostics. However, there continues to be widespread use of non-recommended therapies and variation in the use of therapeutic interventions among hospitals in the United States. Here we review evidence-based management of this common disease in order to optimize resource utilization, decrease healthcare costs, and decrease unnecessary hospitalization. Current evidence does not support the routine use of chest radiographs, viral testing or laboratory evaluation in children with bronchiolitis. In addition, routine administration of bronchodilators, including albuterol and nebulized epinephrine, corticosteroids and hypertonic saline are not recommended for infants and children with bronchiolitis. Intravenous or nasogastric hydration and nutritional support, supplemental oxygen, and respiratory support are recommended. Standardization of bronchiolitis care with evidence based institutional clinical pathways spanning ED to inpatient care can help optimize resource utilization while simultaneously improving care of bronchiolitis and reducing hospital length of stays and costs.",10.1016/j.cpem.2018.02.003,59iwx6ws,"['Abstract', 'Bronchiolitis', 'is', 'the', 'number', 'one', 'cause', 'of', 'hospitalization', 'in', 'infants', 'during', 'the', 'first', 'year', 'of', 'life', 'Clinical', 'guidelines', 'recommend', 'primarily', 'supportive', 'care', 'and', 'discourage', 'use', 'of', 'pharmacotherapies', 'and', 'diagnostics', 'However', 'there', 'continues', 'to', 'be', 'widespread', 'use', 'of', 'non', 'recommended', 'therapies', 'and', 'variation', 'in', 'the', 'use', 'of', 'therapeutic', 'interventions', 'among', 'hospitals', 'in', 'the', 'United', 'States', 'Here', 'we', 'review', 'evidence', 'based', 'management', 'of', 'this', 'common', 'disease', 'in', 'order', 'to', 'optimize', 'resource', 'utilization', 'decrease', 'healthcare', 'costs', 'and', 'decrease', 'unnecessary', 'hospitalization', 'Current', 'evidence', 'does', 'not', 'support', 'the', 'routine', 'use', 'of', 'chest', 'radiographs', 'viral', 'testing', 'or', 'laboratory', 'evaluation', 'in', 'children', 'with', 'bronchiolitis', 'In', 'addition', 'routine', 'administration', 'of', 'bronchodilators', 'including', 'albuterol', 'and', 'nebulized', 'epinephrine', 'corticosteroids', 'and', 'hypertonic', 'saline', 'are', 'not', 'recommended', 'for', 'infants', 'and', 'children', 'with', 'bronchiolitis', 'Intravenous', 'or', 'nasogastric', 'hydration', 'and', 'nutritional', 'support', 'supplemental', 'oxygen', 'and', 'respiratory', 'support', 'are', 'recommended', 'Standardization', 'of', 'bronchiolitis', 'care', 'with', 'evidence', 'based', 'institutional', 'clinical', 'pathways', 'spanning', 'ED', 'to', 'inpatient', 'care', 'can', 'help', 'optimize', 'resource', 'utilization', 'while', 'simultaneously', 'improving', 'care', 'of', 'bronchiolitis', 'and', 'reducing', 'hospital', 'length', 'of', 'stays', 'and', 'costs', '']"
155862,"Clinical features, diagnostics, and outcomes of patients presenting with acute respiratory illness: a comparison of patients with and without COVID-19",2020-05-06,medRxiv,http://medrxiv.org/cgi/content/short/2020.05.02.20082461v1?rss=1; https://doi.org/10.1101/2020.05.02.20082461; https://www.ncbi.nlm.nih.gov/pubmed/32511488/,"BACKGROUND: Emerging data on the clinical presentation, diagnostics, and outcomes of patients with COVID-19 have largely been presented as case series. Few studies have compared these clinical features and outcomes of COVID-19 to other acute respiratory illnesses. METHODS: We examined all patients presenting to an emergency department in San Francisco, California between February 3 and March 31, 2020 with an acute respiratory illness who were tested for SARS-CoV-2. We determined COVID-19 status by PCR and metagenomic next generation sequencing (mNGS). We compared demographics, comorbidities, symptoms, vital signs, and laboratory results including viral diagnostics using PCR and mNGS. Among those hospitalized, we determined differences in treatment (antibiotics, antivirals, respiratory support) and outcomes (ICU admission, ICU interventions, acute respiratory distress syndrome, cardiac injury). FINDINGS: In a cohort of 316 patients, 33 (10%) tested positive for SARS-CoV-2; 31 patients, all without COVID-19, tested positive for another respiratory virus (16%). Among patients with additional viral testing, no co-infections with SARS-CoV-2 were identified by PCR or mNGS. Patients with COVID-19 reported longer symptoms duration (median 7 vs. 3 days), and were more likely to report fever (82% vs. 44%), fatigue (85% vs. 50%), and myalgias (61% vs 27%); p<0.001 for all comparisons. Lymphopenia (55% vs 34%, p=0.018) and bilateral opacities on initial chest radiograph (55% vs. 24%, p=0.001) were more common in patients with COVID-19. Patients with COVID-19 were more often hospitalized (79% vs. 56%, p=0.014). Of 186 hospitalized patients, patients with COVID-19 had longer hospitalizations (median 10.7d vs. 4.7d, p<0.001) and were more likely to develop ARDS (23% vs. 3%, p<0.001). Most comorbidities, home medications, signs and symptoms, vital signs, laboratory results, treatment, and outcomes did not differ by COVID-19 status. INTERPRETATION: While we found differences in clinical features of COVID-19 compared to other acute respiratory illnesses, there was significant overlap in presentation and comorbidities. Patients with COVID-19 were more likely to be admitted to the hospital, have longer hospitalizations and develop ARDS, and were unlikely to have co-existent viral infections. These findings enhance understanding of the clinical characteristics of COVID-19 in comparison to other acute respiratory illnesses.",10.1101/2020.05.02.20082461,jgwqqer5,"['BACKGROUND', 'Emerging', 'data', 'on', 'the', 'clinical', 'presentation', 'diagnostics', 'and', 'outcomes', 'of', 'patients', 'with', 'COVID', '19', 'have', 'largely', 'been', 'presented', 'as', 'case', 'series', 'Few', 'studies', 'have', 'compared', 'these', 'clinical', 'features', 'and', 'outcomes', 'of', 'COVID', '19', 'to', 'other', 'acute', 'respiratory', 'illnesses', 'METHODS', 'We', 'examined', 'all', 'patients', 'presenting', 'to', 'an', 'emergency', 'department', 'in', 'San', 'Francisco', 'California', 'between', 'February', '3', 'and', 'March', '31', '2020', 'with', 'an', 'acute', 'respiratory', 'illness', 'who', 'were', 'tested', 'for', 'SARS', 'CoV', '2', 'We', 'determined', 'COVID', '19', 'status', 'by', 'PCR', 'and', 'metagenomic', 'next', 'generation', 'sequencing', 'mNGS', 'We', 'compared', 'demographics', 'comorbidities', 'symptoms', 'vital', 'signs', 'and', 'laboratory', 'results', 'including', 'viral', 'diagnostics', 'using', 'PCR', 'and', 'mNGS', 'Among', 'those', 'hospitalized', 'we', 'determined', 'differences', 'in', 'treatment', 'antibiotics', 'antivirals', 'respiratory', 'support', 'and', 'outcomes', 'ICU', 'admission', 'ICU', 'interventions', 'acute', 'respiratory', 'distress', 'syndrome', 'cardiac', 'injury', 'FINDINGS', 'In', 'a', 'cohort', 'of', '316', 'patients', '33', '10', 'tested', 'positive', 'for', 'SARS', 'CoV', '2', '31', 'patients', 'all', 'without', 'COVID', '19', 'tested', 'positive', 'for', 'another', 'respiratory', 'virus', '16', 'Among', 'patients', 'with', 'additional', 'viral', 'testing', 'no', 'co', 'infections', 'with', 'SARS', 'CoV', '2', 'were', 'identified', 'by', 'PCR', 'or', 'mNGS', 'Patients', 'with', 'COVID', '19', 'reported', 'longer', 'symptoms', 'duration', 'median', '7', 'vs', '3', 'days', 'and', 'were', 'more', 'likely', 'to', 'report', 'fever', '82', 'vs', '44', 'fatigue', '85', 'vs', '50', 'and', 'myalgias', '61', 'vs', '27', 'p', '0', '001', 'for', 'all', 'comparisons', 'Lymphopenia', '55', 'vs', '34', 'p', '0', '018', 'and', 'bilateral', 'opacities', 'on', 'initial', 'chest', 'radiograph', '55', 'vs', '24', 'p', '0', '001', 'were', 'more', 'common', 'in', 'patients', 'with', 'COVID', '19', 'Patients', 'with', 'COVID', '19', 'were', 'more', 'often', 'hospitalized', '79', 'vs', '56', 'p', '0', '014', 'Of', '186', 'hospitalized', 'patients', 'patients', 'with', 'COVID', '19', 'had', 'longer', 'hospitalizations', 'median', '10', '7d', 'vs', '4', '7d', 'p', '0', '001', 'and', 'were', 'more', 'likely', 'to', 'develop', 'ARDS', '23', 'vs', '3', 'p', '0', '001', 'Most', 'comorbidities', 'home', 'medications', 'signs', 'and', 'symptoms', 'vital', 'signs', 'laboratory', 'results', 'treatment', 'and', 'outcomes', 'did', 'not', 'differ', 'by', 'COVID', '19', 'status', 'INTERPRETATION', 'While', 'we', 'found', 'differences', 'in', 'clinical', 'features', 'of', 'COVID', '19', 'compared', 'to', 'other', 'acute', 'respiratory', 'illnesses', 'there', 'was', 'significant', 'overlap', 'in', 'presentation', 'and', 'comorbidities', 'Patients', 'with', 'COVID', '19', 'were', 'more', 'likely', 'to', 'be', 'admitted', 'to', 'the', 'hospital', 'have', 'longer', 'hospitalizations', 'and', 'develop', 'ARDS', 'and', 'were', 'unlikely', 'to', 'have', 'co', 'existent', 'viral', 'infections', 'These', 'findings', 'enhance', 'understanding', 'of', 'the', 'clinical', 'characteristics', 'of', 'COVID', '19', 'in', 'comparison', 'to', 'other', 'acute', 'respiratory', 'illnesses', '']"
